Table:
begin	end	state
1	19	cytoplasmic
20	41	transmembrane
42	46	non-cytoplasmic
47	66	transmembrane
67	85	cytoplasmic
86	105	transmembrane
106	124	non-cytoplasmic
125	144	transmembrane
145	153	cytoplasmic
154	176	transmembrane
177	195	non-cytoplasmic
196	220	transmembrane
221	240	cytoplasmic
241	261	transmembrane
262	287	non-cytoplasmic
288	309	transmembrane
310	342	cytoplasmic
343	363	transmembrane
364	369	non-cytoplasmic
370	389	transmembrane
390	408	cytoplasmic
409	432	transmembrane
433	437	non-cytoplasmic
438	455	transmembrane
456	472	cytoplasmic

Input:
>Pf6N2E2_5633
MSGQNSHSGELKRGLKNRHIQLIALGGAIGTGLFLGSAGVLKSAGPSMILGYAICGFIAF
MIMRQLGEMIVEEPVAGSFSHFAHKYWGGFAGFLSGWNCWILYILVGMSELTAVGKYIHY
WAPDIPTWVSAAAFFILINVINLANVKVFGEAEFWFAIIKVVAIVGMIALGSYLLVSGHG
GPQASVTNLWSHGGFFPNGVSGLVMAMAIIMFSFGGLEMLGFTAAEADKPKTVIPKAINQ
VIYRILIFYIGALVVLLSLTPWDSLLSTLNASGDAYSGSPFVQVFSMLGSNTAAHILNFV
VLTAALSVYNSGTYCNSRMLLGMAEQGDAPKVLSKIDKRGVPVRSILASAAVTLVAVLLN
YLIPQHALELLMSLVVATLVINWAMISYSHFKFRQHMNQTHQTPLFKALWYPYGNYICLA
FVVFILGVMLLIPGIQVSVYAIPVWVVFMAVCYWIKNKRSARQELAVAAAAK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server